These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13433378)

  • 61. Complication of aortography; factors influencing renal function following aoriography with 70 per cent urokon.
    BEALL AC; CRAWFORD ES; COUVES CM; DEBAKEY ME; MOYER JH
    Surgery; 1958 Mar; 43(3):364-80. PubMed ID: 13647159
    [No Abstract]   [Full Text] [Related]  

  • 62. Relative suitability of urokon 70 per cent and hypaque 90 per cent for use as aortographic contrast media.
    KILLEN DA; LANCE EM; OWENS G
    Surgery; 1959 Mar; 45(3):436-44. PubMed ID: 13635221
    [No Abstract]   [Full Text] [Related]  

  • 63. A plea for caution in the use of sodium acetrizoate (urokon) for aortography.
    LANCE EM; KILLEN DA; SCOTT HW
    Ann Surg; 1959 Jul; 150(1):172. PubMed ID: 13661846
    [No Abstract]   [Full Text] [Related]  

  • 64. Hyperhydration: a method of decreasing the nephrotoxic effects of Urokon as employed in aortography.
    MORRIS GC; CRAWFORD ES; BEALL AC; MOYER JH
    Surg Forum; 1957; 7():319-22. PubMed ID: 13433378
    [No Abstract]   [Full Text] [Related]  

  • 65. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nephrotoxicity and the role of contrast media.
    Aspelin P
    Radiat Med; 2004; 22(6):377-8. PubMed ID: 15648451
    [No Abstract]   [Full Text] [Related]  

  • 67. [Nephrotoxic action of contrast media].
    Kleinrok A; Kudyk T
    Przegl Lek; 2005; 62 Suppl 2():57-60. PubMed ID: 16623122
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Significance of zinc in nephrotoxicity of contrast media used in imaging diagnostics of the cardiovascular system.
    Tubek S; Tubek I
    Biol Trace Elem Res; 2007; 117(1-3):1-5. PubMed ID: 17873387
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contrast-induced nephropathy.
    Kabalan SN; El-Imad BG; Geara AS
    J Med Liban; 2007; 55(1):29-38. PubMed ID: 17489305
    [No Abstract]   [Full Text] [Related]  

  • 70. [Which benefit for patient can we expect from hyperhydration and haemodynamic per and postoperative optimization? (I)].
    Carlier M
    Ann Fr Anesth Reanim; 2005 Feb; 24(2):194-8. PubMed ID: 15737506
    [No Abstract]   [Full Text] [Related]  

  • 71. [Secondary nephropathies in occupational health practice. II. Kidney disorders induced by drug and contrast media].
    Antonowicz-Juchniewicz J; Jodkowska A; Kwiecińska D
    Med Pr; 2006; 57(5):455-68. PubMed ID: 17340988
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
    Rudnick MR; Goldfarb S
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adverse reactions to intravenous iodinated contrast media: an update.
    Namasivayam S; Kalra MK; Torres WE; Small WC
    Curr Probl Diagn Radiol; 2006; 35(4):164-9. PubMed ID: 16814003
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preventing complications of radiographic contrast media: is there a role for dialysis?
    Rodby RA
    Semin Dial; 2007; 20(1):19-23. PubMed ID: 17244114
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk factors and therapy strategies for contrast-induced nephropathy.
    Toprak O; Cirit M
    Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.